Parle, owned by Parle Products, has once again been named India’s top FMCG brand according to the latest Brand Footprint ranking by the Kantar World panel. This marks the 12th consecutive year that Parle has held the top spot, with seven of the top 10 brands being homegrown.
The Brand Footprint study evaluates brands based on Consumer Reach Points (CRPs), a metric that combines brand penetration and frequency of purchase. Parle leads the ranking with an impressive 7.98 billion CRPs, followed closely by Britannia with 7.93 billion CRPs. Both brands saw significant growth, with Parle increasing by 6% and Britannia by 16%.
Hindustan Unilever’s Clinic Plus is the only non-food brand in the top five, despite a 5% decline to 4.14 billion CRPs. “Consumer choice is a very reliable strength test for a brand across market conditions,” said K. Ramakrishnan, Managing Director for South Asia at Kantar’s Worldpanel Division. “As consumers make more frequent purchases, their choices expand, reflecting the constant increase in CRPs.”
Nearly two years ago, Parle Products, known for brands such as Parle-G, Monaco, and Melody, surpassed $2 billion in annual revenues, becoming the first packaged food company in India to reach this milestone. The value of the five-rupee-a-pack Parle-G has grown, particularly during inflationary times when consumers opt for smaller, more affordable packs.
“Following consumer preferences is key. By understanding and delighting our consumers with great value, we ensure their loyalty,” said Mayank Shah, Vice-President at Parle Products. “To stay relevant, we must understand changing consumer dynamics and adapt accordingly.”
The report also examined out-of-home consumption, revealing that nine out of ten top brands in this category are snacking products. Britannia led the out-of-home rankings with 628 million CRPs, followed by Haldiram’s, Cadbury, Balaji, and Parle. Thums Up emerged as the most popular beverage brand outside the home.
While CRPs continue to grow, they are slightly lower than last year. However, over the past five years, CRPs have increased by almost 33%.